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     V617F mutation of JAK2 gene is a point mutation of Somatic cells leading to permanent 
phosphorylation and protein kinase activity of the JAK2 protein. This mutation is a valuable marker in the 
diagnosis of myeloid neoplasms. Development of new techniques can be effective and highly sensitive for 
the detection of the mutation. The aim of this study is designing and executing a molecular beacon probe-
based real-time PCR detect to V617F mutation. Test results were reviewed from a set of wild type and 
cloned JAK2 exon 12 mutated allele genes into plasmid vector and through amplification by Real-Time 
PCR system. The sensitivity and specificity of Molecular Beacon probes design were tested. The results 
showed that the Real-Time PCR system has %100 specificity and % 0.001 sensitivity. Based on the 
results obtained from the molecular beacon probe-based real-time PCR, it was proved that the system is 
able to detect normal and mutant alleles of JAK2 V617F position with high accuracy and a short time in a 
closed tube system. 
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INTRODUCTION 
     Myeloproliferative neoplasms, also known as 
chronic myeloproliferative disorders, are a group 
of hematologic malignancies, derived from 
myeloid stem cell line which occurs mainly in 
adults. Among one of the major characteristics 
of the disorder is the existence of high 
accumulate of one or more hematopoietic cell 
lines in the bone marrow. Mature and immature 
cells in the bone marrow are easily imported to 
the blood stream, leading to an increase of white 
blood cell, hemoglobin, and hematocrit and 
platelet count [1].In 2005, four research groups 
managed to identify G to T single nucleotide 
change in the JAK2 gene, located on 
chromosome 9P at 1849 position (G→T base 
substitution) in exon 14 in a large number of 
patients with polycythemia vera (PV), primary 
thrombocythemia (ET) and Primary 
Myelofibrosis (PMF). Genetic analysis revealed 
that the patients were positive for the JAK2-
V617F mutation, found in almost 90-95% of 
patients with PV and 50% of ET and PMF 
patients [2].High frequency of V617Fmutation 
in Polycythemia Vera (PV) has turned into a 
diagnostic parameter. JAK2, one of four non-
receptor Janus kinase is a member of tyrosine 
kinase, involved as one of the components of 
internal cytokine signal transduction and growth 
factor. JAK2 protein kinase has two domains, 
namely (JH1 and JH2), with only the second 
JH1 possessing enzymatic activity. JH2 domain 
or false domain kinase is a negative regulator of 
kinase activity; through mutation V617F this 
inhibitory function is destroyed. This mutation 
occurs in the of primary stem cells and increases 
sensitivity to cytokines and transmits the 
messages independent of the cytokine 
transduction cascade and leads to the 
downstream message activation of proteins such 
as STAT, inositol phosphatidylinositol 3-kinase 
pathway, the mitogen-activated protein kinase 
and AKT pathways [3].So far, a different 
technique has been used to identify the G → T 
base substitution, which are most commonly 
included in direct sequencing, PCR-RFLP, and 
ARMS. However, these different molecular 
methods have different sensitivities, with ARMS 
method having a sensitivity of 0.01%, while the 
sensitivity of direct sequencing is between 10-
40%. PCR-RFLP method can identify the 
presence of about 5% Mutant allele 




[4].Considering to sensitivity limitation between 
different methods, when the amount of mutated 
cells in the patient is low, the exact identification 
is reduced. The aim of this study is designing, 
execution and the molecular beacon probe-based 
real-time PCR detect to V617F mutation. 
 
METHODS 
     In order to evaluate the function of the 
molecular system designed, several genomic 
DNAs containing normal and mutant alleles of 
the V617F were prepared from the Tehran Noor  
Lab. In order to design suitable primers and 
probes for the implementation of Rt-PCR, gene 
sequence information of JAK2 exon 12 and the 
headquarters of the mutation were obtained, 
through the nucleotide NCBI site.  
Then, V617F G → T mutation position was 
determined on the Jak2 gene sequence and a pair 
of primers was designed that replicated the 
region containing the mutation. PCR product 
was 115 bp. Two Molecular Beacon probes were 
designed for both normal and mutant alleles. 
Primer and probe sequences are shown in Table 
1. 
Table 1. Sequences of primers and probes 
Primers and Probes Sequence 
Forward Primer (Jak-f) AGCAGCAAGTATGATGAGCAAG 
Reverse Primer (Jak-r) GAGAAAGGCATTAGAAAGCCTGTAG 
Probe Beacon Normal (Jak-PN) 6-FAM-GCTCGATTATGGAGTATGTGTCTGTGGAGACGAGC-BHQ1 
Probe Beacon Mutant (Jak-PM) JOE-GCTCGATTATGGAGTATGTTTCTGTGGAGACGAGC-BHQ1 
 
Rt-PCR reaction mixture includes the enzyme 
buffer 1X, dNTP mix at a concentration of 2.0 
mM, 4 mMMg2+,10pmol primers , 10 pmol 
probes, 3U HotstartTaq DNA Polymerase and 
genomic DNA with a concentration of 200 ng. 
In a final volume of 25 ml both in the Rotorgene 
(Qiagen) and Stepone (ABI) at temperature of 
95°C for 10 minutes and 45 cycles in 95°C for 
20 seconds and 60°C for 60 seconds by 
absorbing the signal in two green and yellow  
channels. In order to assess the sensitivity of the 
developed method, a3576 bp (pGH) synthetic 
plasmid containing normal and mutant sequence 
of V617F Jak2 gene was synthesized by 
Generay Biotech Corporation (China). Then, 












the Real Time PCR reaction was performed on 
each dilution. The repeatability of the system 
was also verified by 10 repetitions on each 
dilution over a 30-day period. 
RESULTS 
     Real-Time PCR optimization was performed 
on genomic DNAs with a known genotype. In 
this study the reaction results mentioned on both 
devices showed that the designed MB probes 
identify normal allele on wild type sequence and  
 
probes designed for the mutant allele 
V617FG→T, merely recognize this sequence, 
without any interference together. Figure 1(Part 
a and b) and Figure 2 (Part a and b) show the 
aforementioned reaction results on both devices. 
 
Figure 1. (a) .The result of the fluorescent in the green channel on the Rotor-Gene device. The red sample is a wild type genomic 
DNA, the yellow sample is a positive genomic DNA prepared from the Noor laboratory Tehran, Blue samples or Naz1 positive 




control sample contain mutations that are artificially synthesized, Purple or Naz4 control samples containing the wild type 
sequence, the pink sample was negative controlled. 
Figure 1. (b) . The result of the fluorescent in the green channel on the Rotor-Gene device. The red sample is a wild type 
genomic DNA, the yellow sample is a positive genomic DNA prepared from the Noor laboratory Tehran, Blue samples or Naz1 
positive control sample contain mutations that are artificially synthesized, Purple or Naz4 control samples containing the wild 
type sequence, the pink sample was negative controlled. 
 
Figure 2. (a).Absorbing of signal fluorescent on green channel (Wild type allele) on the device ABI. Sample with black color is a 
wild type genomic DNA, The green color is a unknown sample (without mutation), red sample is a wild type genomic DNA, pink 
sample is a unknown sample (with mutation), Blue Sample or Naz1 positive control samples contain mutations that are 
artificially synthesized, Brown Sample or Naz4 control contain wild type sequence , yellow Sample was negative. 
Figure 2. (b).Absorbing of signal fluorescent on Yellow channel (Mutant allele) on the device ABI. Sample with black color is a 
wild type genomic DNA, The green color is a unknown sample (without mutation), red sample is a wild type genomic DNA, pink 
sample is a unknown sample (with mutation), Blue Sample or Naz1 positive control samples contain mutations that are 
artificially synthesized, Brown Sample or Naz4 control contain wild type sequence, yellow Sample was negative. 
 




 Likewise, our results indicate that the MB 
probes have superior performance on the ABI 
compared to the Rotor-Gene device as the 
fluorescence signal absorption of each channels 
is higher in ABI device. Average sensitivity was 
measured after evaluating the sensitivity of 
normal and mutant probes, were prepared by 
serial dilution of genomic DNA from healthy 












dilution, by a factor of deviation 2.3 % (CV). 
Moreover, the wild type and mutant probes are 
capable of identification respectively of a total 
of 25 copies of the normal allele in 33 Ct and the 
same number of copies of the mutant allele in Ct 
40 in a simultaneous reaction. Besides, the 
fluorescent signal generated by the Natural 
probe was 5 times higher than the mutant allele 
(Table 2). 
 




     Within the past decade, great strides have 
been taken in molecular pathology for MPN 
cancer. Since the middle of the last decade and 
after the discovery of Jak2 mutations in MPN 
cancer, this molecular disorder has become one 
of the most important diagnostic markers in 
negative Philadelphia MPN cancer. All these 
advances in diagnosis and treatment of disease 
are strongly influenced by the correct 
identification of this mutation. Now several 
methods such as sequencing, PCR-RFLP, 
ARMS-PCR and Real-time-PCR based on 
fluorescent probe are available as methods for 
diagnosis However, PCR-RFLP and PCR-
sequencing methods are challenging and time-
consuming. In addition, sequencer device is 
expensive and not affordable in small 
laboratories. ARMS-PCR technique minimizes  
the testing time and is a powerful method for  
 
 
detection of single nucleotide mutations. In any  
case, ARMS-PCR technique based on SYBR 
Green dye still has false-positive results because 
of unwanted amplification [7, 6, 5].In 2011 Wu 
and his colleagues have offered an analysis 
method based on melting point without the use 
of labeled probe to detect V617F mutations. In 
this study, an asymmetric PCR probe with a 
non-fluorescent dye was released by the end of 
the block in the presence of fluorescent color 
saturation and analysis melting point offered. 
Their method is able to be used on three 
different devices and the ability to distinguish 
normal and mutant alleles, respectively [8].In 
2014, Wu and colleagues developed a Multiplex 
Snapback Primer method for the simultaneous 
detection of V617F and MPLW515L/ K 
mutations. Their sensitivity of diagnostic 
method has been 1% with diversity coefficients 
being less than 5% [9].




In 2011, Zhao and his colleagues developed the 
dubbed restriction fragment nested allele-
specific PCR method for  V617F mutation 
detection. Their method consists of three stages: 
amplification of target is done with specific 
primers, PCR products are digested with 
restriction enzyme BSaXI that cuts only wild-
type allele and detection Jak2V617F mutation 
by Allele-specific PCR which is set up in a 
Nested-PCR format. The sensitivity of their 
method was determined to be 0.001% [10]. In 
2013, Zapparoli and his colleagues developed a 
very sensitive method without a probe for the 
quantitative detection ofV617F mutant allele. 
Quantitative threefold Allele Specific PCR 
method is used in a closed tube system which 
eliminates the possibility of contamination from 
previous PCR product. They form a triple 
mutant allele specific amplification, a deoxy 3' -
prime end blocker to inhibit the amplification of 
false positives wild-type allele and a 
enhancerator reaction. In this system, the mutant 
allele was quantitatively detected in comparison 
with JAK2 exon 9. In this study, a Molecular 
Beacon Probes ARMS-PCR is designed into a 
single system based on Real-time PCR. The 
sensitivity achieved in our study is based on the 
plasmid vector containing the normal and 
mutant alleles, being more than 0.001%, which 
is similar to other researchers speculated in this 
study. The execution of the developed method in 
this study was performed on 10 positive 
genomic DNA and 10 negative genomic DNA 
prepared from the Noor laboratory in Tehran, 
whose positivity and negativity was confirmed 
as being 100% through other commercial kits. 
According to the conclusions drawn through the 
designed is able to identify both normal and 
mutant alleles in two distinct color channels. 
Despite the system being appropriate for step 
one ABI, this system is not effective for work on 
Rotor-gene devise because it is non-compliance 
with Molecular Beacon probe system. Similarly, 
in the design, amplification of the normal 
fragment is almost 5 times more than that of the 
mutant fragment, due to the amplification of 
both pieces in one reaction which can reduce the 
sensitivity of mutation detection. However, the 
system was able to amplify the minimal template 
in Ct for the mutant allele. 
CONCLUSION 
     According to the results, it can be claimed 
that the system can be used as suitable close tube 
V617F mutation detection in the clinical 
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